Literature DB >> 20551802

Safe and simplified endoscopic technique in transvaginal NOTES.

Antoine Watrelot1, Joseph Nassif, Wei Seng Law, Jacques Marescaux, Arnaud Wattiez.   

Abstract

Although main obstacles for entry routes (transgastric, transvesical, and transrectal) in natural orifices transluminal endoscopic surgery are closure of the incision and infection issues, the transvaginal route seems to be the most used. There is no doubt that classic colpotomy is a valid option. Nevertheless, this approach can be difficult and time consuming. From our experience with fertiloscopy via vaginal access and using an existing disposable trocar, we describe a new safe and simple technique for transvaginal natural orifices transluminal endoscopic surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20551802     DOI: 10.1097/SLE.0b013e3181df9b6f

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  4 in total

Review 1.  Natural Orifice Surgery (NOS)-the next step in the evolution of minimally invasive surgery.

Authors:  Tahar Benhidjeb; Michael Stark
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-03-01

2.  A comparison of NOTES transvaginal and laparoscopic cholecystectomy procedures based upon task analysis.

Authors:  Arun Nemani; Ganesh Sankaranarayanan; Jaisa S Olasky; Souheil Adra; Kurt E Roberts; Lucian Panait; Steven D Schwaitzberg; Daniel B Jones; Suvranu De
Journal:  Surg Endosc       Date:  2014-03-12       Impact factor: 4.584

3.  Graphic and haptic simulation for transvaginal cholecystectomy training in NOTES.

Authors:  Jun J Pan; Woojin Ahn; Saurabh Dargar; Tansel Halic; Bai C Li; Ganesh Sankaranarayanan; Kurt Roberts; Steven Schwaitzberg; Suvranu De
Journal:  J Biomed Inform       Date:  2016-03-12       Impact factor: 6.317

4.  Obese women's perception of bariatric trans-vaginal NOTES.

Authors:  Stefano Rocchietto; Gitana Scozzari; Alberto Arezzo; Mario Morino
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.